Tascit
Formulation
Each extended release tablet contains:  
Potassium Citrate (as monohydrate) 1080 mg (10 mEq) or 1620 mg (15mEq)

Potassium Citrate

Tascit®

Prescription Drug

Indication

For the management of:

  • Renal tubular acidosis (RTA) with calcium stones
  • Hypocitraturic calcium oxalate nephrolithiasis of any etiology
  • Uric acid lithiasis with or without calcium stones

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.